Form 8.5 (EPT/RI)- Dechra Pharmaceuticals plc

Morgan Stanley & Co. Int'l plc
18 December 2023
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1.         KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley & Co. International plc

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree

Dechra Pharmaceuticals plc

(c) Name of the party to the offer with which exempt principal trader is connected:

EQT (EQT X EUR SCSp and EQT X USD SCSp)

(d) Date dealing undertaken:

15 December 2023

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

     If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a)        Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

1p ordinary

PURCHASES

215,753

38.4800 GBP

38.3800 GBP

1p ordinary

SALES

212,060

38.4800 GBP

38.3800 GBP

 

(b)        Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

1p ordinary

CFD

increasing a long position

143

38.3968 GBP

1p ordinary

CFD

increasing a long position

1,818

38.4000 GBP

1p ordinary

CFD

increasing a long position

461

38.4000 GBP

1p ordinary

CFD

increasing a long position

3,755

38.4025 GBP

1p ordinary

CFD

increasing a long position

20,109

38.4381 GBP

1p ordinary

CFD

increasing a short position

690

38.3800 GBP

1p ordinary

CFD

increasing a short position

47

38.3998 GBP

1p ordinary

CFD

increasing a short position

100

38.4000 GBP

1p ordinary

CFD

increasing a short position

49

38.4000 GBP

1p ordinary

CFD

increasing a short position

1,040

38.4000 GBP

1p ordinary

CFD

increasing a short position

1,875

38.4063 GBP

1p ordinary

CFD

increasing a short position

412

38.4200 GBP

1p ordinary

CFD

increasing a long position

2

38.4000 GBP

1p ordinary

CFD

increasing a long position

199

38.4200 GBP

1p ordinary

CFD

reducing a long position

68

38.4000 GBP

1p ordinary

CFD

reducing a long position

199

38.4000 GBP

1p ordinary

CFD

reducing a short position

1,040

38.4000 GBP

1p ordinary

CFD

reducing a short position

292

38.4000 GBP

1p ordinary

CFD

reducing a short position

290

38.4117 GBP

1p ordinary

CFD

reducing a short position

8,209

38.4223 GBP

 

(c)        Stock-settled derivative transactions (including options)

 

(i)         Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii)        Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

N/A

N/A

N/A

N/A

N/A

 

(d)        Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

3.         OTHER INFORMATION

 

(a)        Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included.  If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

(b)        Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

NONE

 

 

 

Date of disclosure:

18 December 2023

Contact name:

Craig Horsley

Telephone number:

+44 141 245-7736

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings